Locoregional Failure 10 Years After Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen Without Irradiation: Experience of the Eastern Cooperative Oncology Group von RECHT, A, GRAY, R, DAVIDSON, N. E, FOWBLE, B. L, SOLIN, L. J, CUMMINGS, F. J, FALKSON, G, FALKSON, H. C, IV, S. G. T, TORMEY, D. C

Volltext

Postchemotherapy Adjuvant Tamoxifen Therapy Beyond Five Years in Patients With Lymph Node-Positive Breast Cancer von Tormey, Douglass C., Gray, Robert, Falkson, Hendre C.

Volltext

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma von FALKSON, C. I, FALKSON, G, FALKSON, H. C

Volltext

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer von Falkson, C. I., Falkson, H. C.

Volltext

A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer von RAATS, J. I, FALKSON, G, FALKSON, H. C

Volltext

Prognostic factors in metastatic malignant melanoma : An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria... von FALKSON, C. I, FALKSON, H. C

Volltext

Prognostic factors for survival in hepatocellular carcinoma von FALKSON, G, CNAAN, A, SCHUTT, A. J, RYAN, L. M, FALKSON, H. C

Volltext

Phase II trial of fotemustine in patients with metastatic malignant melanoma von FALKSON, C. I, FALKSON, G, FALKSON, H. C

Volltext

A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer von FALKSON, C. I, FALKSON, G, FALKSON, C. B, FALKSON, H. C

Volltext

High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting von FALKSON, H. C, FALKSON, C. I, FALKSON, G

Volltext

Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer von Loprinzi, C L, Tormey, D C, Rasmussen, P, Falkson, G, Davis, T E, Falkson, H C, Chang, A Y

Volltext

Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer von FALKSON, C. I, FALKSON, H. C, FALKSON, G

Volltext

Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer von Falkson, Geoffrey, Raats, Johann I., Falkson, HendréC.

Volltext

High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer von FALKSON, C. I, FALKSON, H. C, FALKSON, G

Volltext

Malignant pleural mesothelioma treatment the current state of the art von Falkson, Geoffrey, Alberts, Albert S., Falkson, H.C.

Volltext

FIVB plus GM-CSF in metastatic colorectal cancer von FALKSON, C. I, FALKSON, G, FALKSON, H. C, UYS, A, KEREN-ROSENBERG, S

Volltext

Prognostic factors affecting the survival of patients with multiple myeloma : a retrospective analysis of 86 patients von RAPOPORT, B. L, FALKSON, H. C, FALKSON, G

Volltext

Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative... von Falkson, H C, Gray, R, Wolberg, W H, Gillchrist, K W, Harris, J E, Tormey, D C, Falkson, G

Volltext

Ifosfamide and Mesna in the treatment of malignant disease Mesna as urothelial protector von FALKSON, C. I, FALKSON, H. C, FALKSON, G

Volltext

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer von Tormey, D C, Weinberg, V E, Holland, J F, Weiss, R B, Glidewell, O J, Perloff, M, Falkson, G, Falkson, H C, Henry, P H, Leone, L A

Volltext